Synergy scores were normalized using Min-Max Scaling to facilitate visual comparisons.
| DrugCom Name |
DrugCom ID |
Component Drug |
Indication |
REF |
|
10-hydroxycamptothecin + Aminolevulinic Acid Hydrochloride
|
DCV73TI
|
10-hydroxycamptothecin
|
Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)
|
[2] |
|
10-hydroxycamptothecin + Aminolevulinic Acid Hydrochloride
|
DCBA02B
|
10-hydroxycamptothecin
|
Pleural epithelioid mesothelioma (Cell Line: NCI-H226)
|
[3] |
|
ABIRATERONE + Aminolevulinic Acid Hydrochloride
|
DC0BUPZ
|
ABIRATERONE
|
Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)
|
[2] |
|
ABIRATERONE + Aminolevulinic Acid Hydrochloride
|
DCP5BYH
|
ABIRATERONE
|
Renal cell carcinoma (Cell Line: UO-31)
|
[2] |
|
ABIRATERONE + Aminolevulinic Acid Hydrochloride
|
DCU5GH5
|
ABIRATERONE
|
Malignant melanoma (Cell Line: UACC62)
|
[3] |
|
ABIRATERONE + Aminolevulinic Acid Hydrochloride
|
DCMOKH0
|
ABIRATERONE
|
Melanoma (Cell Line: SK-MEL-2)
|
[3] |
|
Aminolevulinic Acid Hydrochloride + Pentostatin
|
DCEGBRN
|
Pentostatin
|
Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)
|
[2] |
|
Aminolevulinic Acid Hydrochloride + Pentostatin
|
DCVFW81
|
Pentostatin
|
Papillary renal cell carcinoma (Cell Line: ACHN)
|
[2] |
|
Aminolevulinic Acid Hydrochloride + Pentostatin
|
DC1B7TL
|
Pentostatin
|
Plasma cell myeloma (Cell Line: RPMI-8226)
|
[2] |
|
Aminolevulinic Acid Hydrochloride + Cyclophosphamide
|
DCWTNWI
|
Cyclophosphamide
|
Glioma (Cell Line: SF-539)
|
[2] |
|
Aminolevulinic Acid Hydrochloride + Arsenic trioxide
|
DC3RF34
|
Arsenic trioxide
|
Clear cell renal cell carcinoma (Cell Line: 786-0)
|
[2] |
|
Aminolevulinic Acid Hydrochloride + Topetecan
|
DCUBEF9
|
Topetecan
|
Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)
|
[2] |
|
Aminolevulinic Acid Hydrochloride + Ifosfamide
|
DC5CADG
|
Ifosfamide
|
Clear cell renal cell carcinoma (Cell Line: CAKI-1)
|
[2] |
|
Aminolevulinic Acid Hydrochloride + Mitomycin
|
DCI7VGK
|
Mitomycin
|
Anaplastic large cell lymphoma (Cell Line: SR)
|
[2] |
|
Aminolevulinic Acid Hydrochloride + Cisplatin
|
DCQTV9L
|
Cisplatin
|
Adult acute myeloid leukemia (Cell Line: HL-60(TB))
|
[2] |
|
Aminolevulinic Acid Hydrochloride + Cisplatin
|
DCHI9QC
|
Cisplatin
|
Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)
|
[2] |
|
Aminolevulinic Acid Hydrochloride + Cisplatin
|
DCL2CQ9
|
Cisplatin
|
Anaplastic large cell lymphoma (Cell Line: SR)
|
[2] |
|
Aminolevulinic Acid Hydrochloride + Cisplatin
|
DCAS2AV
|
Cisplatin
|
Plasma cell myeloma (Cell Line: RPMI-8226)
|
[2] |
|
Aminolevulinic Acid Hydrochloride + Chlorambucil
|
DCM3A6C
|
Chlorambucil
|
Glioma (Cell Line: SF-539)
|
[2] |
|
Aminolevulinic Acid Hydrochloride + Chlorambucil
|
DC2WM90
|
Chlorambucil
|
Papillary renal cell carcinoma (Cell Line: ACHN)
|
[2] |
|
Aminolevulinic Acid Hydrochloride + ER819762
|
DC4YMKM
|
ER819762
|
Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)
|
[2] |
|
Aminolevulinic Acid Hydrochloride + ER819762
|
DC6R5BP
|
ER819762
|
Chronic myelogenous leukemia (Cell Line: K-562)
|
[2] |
|
Aminolevulinic Acid Hydrochloride + ER819762
|
DC44JHR
|
ER819762
|
Papillary renal cell carcinoma (Cell Line: ACHN)
|
[2] |
|
Aminolevulinic Acid Hydrochloride + ER819762
|
DC83HYH
|
ER819762
|
Plasma cell myeloma (Cell Line: RPMI-8226)
|
[2] |
|
Aminolevulinic Acid Hydrochloride + Busulfan
|
DC3T23Z
|
Busulfan
|
Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)
|
[2] |
|
Aminolevulinic Acid Hydrochloride + Busulfan
|
DC7HH8E
|
Busulfan
|
Anaplastic large cell lymphoma (Cell Line: SR)
|
[2] |
|
Aminolevulinic Acid Hydrochloride + Pentostatin
|
DCX1T1T
|
Pentostatin
|
Colon carcinoma (Cell Line: KM12)
|
[4] |
|
Aminolevulinic Acid Hydrochloride + Pentostatin
|
DCXMCQM
|
Pentostatin
|
Invasive ductal carcinoma (Cell Line: HS 578T)
|
[4] |
|
Aminolevulinic Acid Hydrochloride + Ifosfamide
|
DC9HCIL
|
Ifosfamide
|
Carcinoma (Cell Line: MCF7)
|
[4] |
|
Aminolevulinic Acid Hydrochloride + Pentostatin
|
DCLHD5N
|
Pentostatin
|
Adenocarcinoma (Cell Line: NCIH23)
|
[3] |
|
Aminolevulinic Acid Hydrochloride + Pentostatin
|
DCLCIIV
|
Pentostatin
|
Amelanotic melanoma (Cell Line: MDA-MB-435)
|
[3] |
|
Aminolevulinic Acid Hydrochloride + Pentostatin
|
DCXM8OJ
|
Pentostatin
|
Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)
|
[3] |
|
Aminolevulinic Acid Hydrochloride + Cyclophosphamide
|
DCFB6XR
|
Cyclophosphamide
|
Adenocarcinoma (Cell Line: HCT-15)
|
[3] |
|
Aminolevulinic Acid Hydrochloride + Arsenic trioxide
|
DC2M1J9
|
Arsenic trioxide
|
High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5)
|
[3] |
|
Aminolevulinic Acid Hydrochloride + Arsenic trioxide
|
DCQLAMF
|
Arsenic trioxide
|
Large cell lung carcinoma (Cell Line: NCI-H460)
|
[3] |
|
Aminolevulinic Acid Hydrochloride + Arsenic trioxide
|
DC7OB8J
|
Arsenic trioxide
|
Malignant melanoma (Cell Line: LOX IMVI)
|
[3] |
|
Aminolevulinic Acid Hydrochloride + Arsenic trioxide
|
DC90TGY
|
Arsenic trioxide
|
Melanoma (Cell Line: SK-MEL-2)
|
[3] |
|
Aminolevulinic Acid Hydrochloride + Topetecan
|
DCH94U6
|
Topetecan
|
Adenocarcinoma (Cell Line: HCC-2998)
|
[3] |
|
Aminolevulinic Acid Hydrochloride + Ifosfamide
|
DCBYFUS
|
Ifosfamide
|
High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4)
|
[3] |
|
Aminolevulinic Acid Hydrochloride + Ifosfamide
|
DC5ZKMV
|
Ifosfamide
|
Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)
|
[3] |
|
Aminolevulinic Acid Hydrochloride + Mitomycin
|
DCFCZI3
|
Mitomycin
|
Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)
|
[3] |
|
Aminolevulinic Acid Hydrochloride + Altretamine
|
DCMP1RS
|
Altretamine
|
High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5)
|
[3] |
|
Aminolevulinic Acid Hydrochloride + Cisplatin
|
DCA6KKK
|
Cisplatin
|
Adenocarcinoma (Cell Line: HCT116)
|
[3] |
|
Aminolevulinic Acid Hydrochloride + Chlorambucil
|
DCZEK80
|
Chlorambucil
|
Adenocarcinoma (Cell Line: A549)
|
[3] |
|
Aminolevulinic Acid Hydrochloride + Chlorambucil
|
DCTM492
|
Chlorambucil
|
Large cell lung carcinoma (Cell Line: NCI-H460)
|
[3] |
|
Aminolevulinic Acid Hydrochloride + Chlorambucil
|
DCOV81U
|
Chlorambucil
|
Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)
|
[3] |
|
Aminolevulinic Acid Hydrochloride + ER819762
|
DC2OF28
|
ER819762
|
Lung adenocarcinoma (Cell Line: HOP-62)
|
[3] |
|
Aminolevulinic Acid Hydrochloride + ER819762
|
DCXWDTV
|
ER819762
|
Lung adenocarcinoma (Cell Line: EKVX)
|
[3] |
|
Aminolevulinic Acid Hydrochloride + ER819762
|
DCMYTTK
|
ER819762
|
Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)
|
[3] |
|
Aminolevulinic Acid Hydrochloride + ER819762
|
DCHNT1L
|
ER819762
|
Pleural epithelioid mesothelioma (Cell Line: NCI-H226)
|
[3] |
|
Aminolevulinic Acid Hydrochloride + PMID28870136-Compound-43
|
DC1N42X
|
PMID28870136-Compound-43
|
Cutaneous melanoma (Cell Line: SK-MEL-28)
|
[3] |
|
Aminolevulinic Acid Hydrochloride + PMID28870136-Compound-43
|
DCU3USM
|
PMID28870136-Compound-43
|
Melanoma (Cell Line: UACC-257)
|
[3] |
|
Amonafide + Aminolevulinic Acid Hydrochloride
|
DCY4Q3B
|
Amonafide
|
Adenocarcinoma (Cell Line: HCT116)
|
[2] |
|
Amonafide + Aminolevulinic Acid Hydrochloride
|
DCT354A
|
Amonafide
|
Adenocarcinoma (Cell Line: HT29)
|
[2] |
|
Amonafide + Aminolevulinic Acid Hydrochloride
|
DCUW1HF
|
Amonafide
|
Adult acute myeloid leukemia (Cell Line: HL-60(TB))
|
[2] |
|
Amonafide + Aminolevulinic Acid Hydrochloride
|
DCOXEXE
|
Amonafide
|
Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)
|
[2] |
|
Amonafide + Aminolevulinic Acid Hydrochloride
|
DCWNOS3
|
Amonafide
|
Anaplastic large cell lymphoma (Cell Line: SR)
|
[2] |
|
Amonafide + Aminolevulinic Acid Hydrochloride
|
DCI9PV3
|
Amonafide
|
Clear cell renal cell carcinoma (Cell Line: A498)
|
[2] |
|
Amonafide + Aminolevulinic Acid Hydrochloride
|
DC1G1MF
|
Amonafide
|
Large cell lung carcinoma (Cell Line: NCI-H460)
|
[2] |
|
Amonafide + Aminolevulinic Acid Hydrochloride
|
DCN50QR
|
Amonafide
|
Renal cell carcinoma (Cell Line: SN12C)
|
[2] |
|
Amonafide + Aminolevulinic Acid Hydrochloride
|
DC3MMRI
|
Amonafide
|
Colon adenocarcinoma (Cell Line: COLO 205)
|
[4] |
|
Amonafide + Aminolevulinic Acid Hydrochloride
|
DCKTNFA
|
Amonafide
|
Invasive ductal carcinoma (Cell Line: HS 578T)
|
[4] |
|
Amonafide + Aminolevulinic Acid Hydrochloride
|
DC9QZGS
|
Amonafide
|
Invasive ductal carcinoma (Cell Line: T-47D)
|
[4] |
|
Anastrozole + Aminolevulinic Acid Hydrochloride
|
DC83HRV
|
Anastrozole
|
Adenocarcinoma (Cell Line: HCT116)
|
[2] |
|
Anastrozole + Aminolevulinic Acid Hydrochloride
|
DCQTZ1J
|
Anastrozole
|
Adult acute myeloid leukemia (Cell Line: HL-60(TB))
|
[2] |
|
Anastrozole + Aminolevulinic Acid Hydrochloride
|
DCJ042Z
|
Anastrozole
|
Large cell lung carcinoma (Cell Line: NCI-H460)
|
[2] |
|
Anastrozole + Aminolevulinic Acid Hydrochloride
|
DCQ79CS
|
Anastrozole
|
Melanoma (Cell Line: SK-MEL-2)
|
[2] |
|
Anastrozole + Aminolevulinic Acid Hydrochloride
|
DC0I3JT
|
Anastrozole
|
Invasive ductal carcinoma (Cell Line: BT-549)
|
[4] |
|
Arfolitixorin + Aminolevulinic Acid Hydrochloride
|
DC4XK0M
|
Arfolitixorin
|
Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)
|
[2] |
|
Arfolitixorin + Aminolevulinic Acid Hydrochloride
|
DCD3VLZ
|
Arfolitixorin
|
Anaplastic large cell lymphoma (Cell Line: SR)
|
[2] |
|
Arfolitixorin + Aminolevulinic Acid Hydrochloride
|
DCN8QZU
|
Arfolitixorin
|
Invasive ductal carcinoma (Cell Line: BT-549)
|
[4] |
|
Arfolitixorin + Aminolevulinic Acid Hydrochloride
|
DCLPFO0
|
Arfolitixorin
|
Adenocarcinoma (Cell Line: HT29)
|
[3] |
|
Arfolitixorin + Aminolevulinic Acid Hydrochloride
|
DCBRZMT
|
Arfolitixorin
|
Melanoma (Cell Line: SK-MEL-2)
|
[3] |
|
Azacitidine + Aminolevulinic Acid Hydrochloride
|
DCNEY8L
|
Azacitidine
|
Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)
|
[2] |
|
Azacitidine + Aminolevulinic Acid Hydrochloride
|
DCYIWI1
|
Azacitidine
|
Anaplastic large cell lymphoma (Cell Line: SR)
|
[2] |
|
Azacitidine + Aminolevulinic Acid Hydrochloride
|
DCQDH35
|
Azacitidine
|
Astrocytoma (Cell Line: U251)
|
[2] |
|
Azacitidine + Aminolevulinic Acid Hydrochloride
|
DCRPCBI
|
Azacitidine
|
Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)
|
[2] |
|
Azacitidine + Aminolevulinic Acid Hydrochloride
|
DCDHFSK
|
Azacitidine
|
Large cell lung carcinoma (Cell Line: NCI-H460)
|
[2] |
|
Azacitidine + Aminolevulinic Acid Hydrochloride
|
DCJDJZL
|
Azacitidine
|
Papillary renal cell carcinoma (Cell Line: ACHN)
|
[2] |
|
Bendamustine hydrochloride + Aminolevulinic Acid Hydrochloride
|
DCSHORZ
|
Bendamustine hydrochloride
|
Chronic myelogenous leukemia (Cell Line: K-562)
|
[2] |
|
Bendamustine hydrochloride + Aminolevulinic Acid Hydrochloride
|
DCWHGFZ
|
Bendamustine hydrochloride
|
Adenocarcinoma (Cell Line: DU-145)
|
[3] |
|
Bendamustine hydrochloride + Aminolevulinic Acid Hydrochloride
|
DCJ5PU8
|
Bendamustine hydrochloride
|
High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5)
|
[3] |
|
Bendamustine hydrochloride + Aminolevulinic Acid Hydrochloride
|
DCNF8PF
|
Bendamustine hydrochloride
|
Large cell lung carcinoma (Cell Line: NCI-H460)
|
[3] |
|
Bendamustine hydrochloride + Aminolevulinic Acid Hydrochloride
|
DCNPA37
|
Bendamustine hydrochloride
|
Malignant melanoma (Cell Line: LOX IMVI)
|
[3] |
|
BIO-300 + Aminolevulinic Acid Hydrochloride
|
DCHZZYB
|
BIO-300
|
Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)
|
[2] |
|
BIO-300 + Aminolevulinic Acid Hydrochloride
|
DCQTOKG
|
BIO-300
|
Anaplastic large cell lymphoma (Cell Line: SR)
|
[2] |
|
BIO-300 + Aminolevulinic Acid Hydrochloride
|
DCJ01D6
|
BIO-300
|
Clear cell renal cell carcinoma (Cell Line: A498)
|
[2] |
|
BIO-300 + Aminolevulinic Acid Hydrochloride
|
DCR5528
|
BIO-300
|
Glioma (Cell Line: SF-539)
|
[2] |
|
BIO-300 + Aminolevulinic Acid Hydrochloride
|
DC2TAQD
|
BIO-300
|
Papillary renal cell carcinoma (Cell Line: ACHN)
|
[2] |
|
BIO-300 + Aminolevulinic Acid Hydrochloride
|
DCPOU65
|
BIO-300
|
Colon adenocarcinoma (Cell Line: COLO 205)
|
[4] |
|
BIO-300 + Aminolevulinic Acid Hydrochloride
|
DCLX5S7
|
BIO-300
|
Invasive ductal carcinoma (Cell Line: T-47D)
|
[4] |
|
BIO-300 + Aminolevulinic Acid Hydrochloride
|
DCHZ7S5
|
BIO-300
|
Adenocarcinoma (Cell Line: OVCAR3)
|
[3] |
|
BIO-300 + Aminolevulinic Acid Hydrochloride
|
DCARRH9
|
BIO-300
|
Large cell lung carcinoma (Cell Line: NCI-H460)
|
[3] |
|
Bleomycin + Aminolevulinic Acid Hydrochloride
|
DC5Y2BT
|
Bleomycin
|
Adult acute myeloid leukemia (Cell Line: HL-60(TB))
|
[2] |
|
Bleomycin + Aminolevulinic Acid Hydrochloride
|
DCFI5K5
|
Bleomycin
|
Clear cell renal cell carcinoma (Cell Line: CAKI-1)
|
[2] |
|
Bleomycin + Aminolevulinic Acid Hydrochloride
|
DCMXZ8H
|
Bleomycin
|
Breast adenocarcinoma (Cell Line: MDA-MB-468)
|
[4] |
|
Bleomycin + Aminolevulinic Acid Hydrochloride
|
DCRFX81
|
Bleomycin
|
Adenocarcinoma (Cell Line: OVCAR3)
|
[3] |
|
Bleomycin + Aminolevulinic Acid Hydrochloride
|
DC1GX5D
|
Bleomycin
|
Large cell lung carcinoma (Cell Line: NCI-H460)
|
[3] |
|
Cabazitaxel + Aminolevulinic Acid Hydrochloride
|
DCPX0MS
|
Cabazitaxel
|
Glioma (Cell Line: SF-539)
|
[2] |
|
Cabazitaxel + Aminolevulinic Acid Hydrochloride
|
DCA4TIZ
|
Cabazitaxel
|
Malignant melanoma (Cell Line: UACC62)
|
[2] |
|
Crizotinib + Aminolevulinic Acid Hydrochloride
|
DC22C4K
|
Crizotinib
|
Adult acute myeloid leukemia (Cell Line: HL-60(TB))
|
[2] |
|
Dacarbazine + Aminolevulinic Acid Hydrochloride
|
DCRXU6F
|
Dacarbazine
|
Adenocarcinoma (Cell Line: DU-145)
|
[2] |
|
Dacarbazine + Aminolevulinic Acid Hydrochloride
|
DCQO9C9
|
Dacarbazine
|
Adult acute myeloid leukemia (Cell Line: HL-60(TB))
|
[2] |
|
Dacarbazine + Aminolevulinic Acid Hydrochloride
|
DC0TZAB
|
Dacarbazine
|
Anaplastic large cell lymphoma (Cell Line: SR)
|
[2] |
|
Dacarbazine + Aminolevulinic Acid Hydrochloride
|
DCXE0IH
|
Dacarbazine
|
Glioblastoma (Cell Line: SNB-75)
|
[2] |
|
Dacarbazine + Aminolevulinic Acid Hydrochloride
|
DCRLXLH
|
Dacarbazine
|
Large cell lung carcinoma (Cell Line: NCI-H460)
|
[2] |
|
Dacarbazine + Aminolevulinic Acid Hydrochloride
|
DCT90ZX
|
Dacarbazine
|
Pleural epithelioid mesothelioma (Cell Line: NCI-H226)
|
[2] |
|
Dacarbazine + Aminolevulinic Acid Hydrochloride
|
DCFHJYG
|
Dacarbazine
|
Invasive ductal carcinoma (Cell Line: BT-549)
|
[4] |
|
Dasatinib + Aminolevulinic Acid Hydrochloride
|
DCYSDWO
|
Dasatinib
|
Adenocarcinoma (Cell Line: DU-145)
|
[2] |
|
Dasatinib + Aminolevulinic Acid Hydrochloride
|
DCFY9SW
|
Dasatinib
|
Adenocarcinoma (Cell Line: A549)
|
[2] |
|
Dasatinib + Aminolevulinic Acid Hydrochloride
|
DCHLBS5
|
Dasatinib
|
Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)
|
[2] |
|
Dasatinib + Aminolevulinic Acid Hydrochloride
|
DCWOWJH
|
Dasatinib
|
Anaplastic large cell lymphoma (Cell Line: SR)
|
[2] |
|
Dasatinib + Aminolevulinic Acid Hydrochloride
|
DC0A8Z6
|
Dasatinib
|
Astrocytoma (Cell Line: U251)
|
[2] |
|
Dasatinib + Aminolevulinic Acid Hydrochloride
|
DCVNBZN
|
Dasatinib
|
Large cell lung carcinoma (Cell Line: NCI-H460)
|
[2] |
|
Dasatinib + Aminolevulinic Acid Hydrochloride
|
DCBDMIE
|
Dasatinib
|
Breast adenocarcinoma (Cell Line: MDA-MB-468)
|
[4] |
|
Dexrazoxane + Aminolevulinic Acid Hydrochloride
|
DCOX77X
|
Dexrazoxane
|
Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)
|
[2] |
|
Dexrazoxane + Aminolevulinic Acid Hydrochloride
|
DCRW49A
|
Dexrazoxane
|
Plasma cell myeloma (Cell Line: RPMI-8226)
|
[2] |
|
Dexrazoxane + Aminolevulinic Acid Hydrochloride
|
DC28NMA
|
Dexrazoxane
|
Renal cell carcinoma (Cell Line: SN12C)
|
[2] |
|
Dexrazoxane + Aminolevulinic Acid Hydrochloride
|
DCVSYU5
|
Dexrazoxane
|
Invasive ductal carcinoma (Cell Line: BT-549)
|
[4] |
|
Dexrazoxane + Aminolevulinic Acid Hydrochloride
|
DCDK6IJ
|
Dexrazoxane
|
Invasive ductal carcinoma (Cell Line: HS 578T)
|
[4] |
|
Dexrazoxane + Aminolevulinic Acid Hydrochloride
|
DCV5S0E
|
Dexrazoxane
|
Melanoma (Cell Line: SK-MEL-2)
|
[3] |
|
DFN-15 + Aminolevulinic Acid Hydrochloride
|
DCV6Q9M
|
DFN-15
|
Carcinoma (Cell Line: RXF 393)
|
[4] |
|
DFN-15 + Aminolevulinic Acid Hydrochloride
|
DCR6PBH
|
DFN-15
|
Adenocarcinoma (Cell Line: OVCAR3)
|
[3] |
|
DFN-15 + Aminolevulinic Acid Hydrochloride
|
DCR974N
|
DFN-15
|
Adenocarcinoma (Cell Line: A549)
|
[3] |
|
DFN-15 + Aminolevulinic Acid Hydrochloride
|
DCGIN10
|
DFN-15
|
Adenocarcinoma (Cell Line: HT29)
|
[3] |
|
DFN-15 + Aminolevulinic Acid Hydrochloride
|
DC6KSYC
|
DFN-15
|
Large cell lung carcinoma (Cell Line: NCI-H460)
|
[3] |
|
DFN-15 + Aminolevulinic Acid Hydrochloride
|
DCTVX8C
|
DFN-15
|
Malignant melanoma (Cell Line: LOX IMVI)
|
[3] |
|
DFN-15 + Aminolevulinic Acid Hydrochloride
|
DCJY69O
|
DFN-15
|
Prostate carcinoma (Cell Line: PC-3)
|
[3] |
|
Digitoxin + Aminolevulinic Acid Hydrochloride
|
DC6TW8M
|
Digitoxin
|
Adult acute myeloid leukemia (Cell Line: HL-60(TB))
|
[2] |
|
Digitoxin + Aminolevulinic Acid Hydrochloride
|
DCT500K
|
Digitoxin
|
Anaplastic large cell lymphoma (Cell Line: SR)
|
[2] |
|
Digitoxin + Aminolevulinic Acid Hydrochloride
|
DC2VQ89
|
Digitoxin
|
Large cell lung carcinoma (Cell Line: NCI-H460)
|
[2] |
|
Digitoxin + Aminolevulinic Acid Hydrochloride
|
DC8363F
|
Digitoxin
|
Pleural epithelioid mesothelioma (Cell Line: NCI-H226)
|
[2] |
|
Digitoxin + Aminolevulinic Acid Hydrochloride
|
DCW291W
|
Digitoxin
|
Breast adenocarcinoma (Cell Line: MDA-MB-468)
|
[4] |
|
Docetaxel + Aminolevulinic Acid Hydrochloride
|
DCUCUWK
|
Docetaxel
|
Adenocarcinoma (Cell Line: HCC-2998)
|
[2] |
|
Docetaxel + Aminolevulinic Acid Hydrochloride
|
DCL10C2
|
Docetaxel
|
Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)
|
[2] |
|
Docetaxel + Aminolevulinic Acid Hydrochloride
|
DCW4SS0
|
Docetaxel
|
Anaplastic large cell lymphoma (Cell Line: SR)
|
[2] |
|
Docetaxel + Aminolevulinic Acid Hydrochloride
|
DCI06D4
|
Docetaxel
|
Glioma (Cell Line: SF-539)
|
[2] |
|
Epirubicin + Aminolevulinic Acid Hydrochloride
|
DCVTSF8
|
Epirubicin
|
Chronic myelogenous leukemia (Cell Line: K-562)
|
[2] |
|
Epirubicin + Aminolevulinic Acid Hydrochloride
|
DCXXOX8
|
Epirubicin
|
Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)
|
[3] |
|
Estramustine + Aminolevulinic Acid Hydrochloride
|
DCZL1ZQ
|
Estramustine
|
Adult acute myeloid leukemia (Cell Line: HL-60(TB))
|
[2] |
|
Estramustine + Aminolevulinic Acid Hydrochloride
|
DCA8GKF
|
Estramustine
|
Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)
|
[2] |
|
Estramustine + Aminolevulinic Acid Hydrochloride
|
DCY0QWA
|
Estramustine
|
Anaplastic large cell lymphoma (Cell Line: SR)
|
[2] |
|
Estramustine + Aminolevulinic Acid Hydrochloride
|
DCNVSHS
|
Estramustine
|
Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)
|
[2] |
|
Estramustine + Aminolevulinic Acid Hydrochloride
|
DCFRIED
|
Estramustine
|
Renal cell carcinoma (Cell Line: SN12C)
|
[2] |
|
Estramustine + Aminolevulinic Acid Hydrochloride
|
DCAG39G
|
Estramustine
|
Adenocarcinoma (Cell Line: OVCAR3)
|
[3] |
|
Estramustine + Aminolevulinic Acid Hydrochloride
|
DCNDLEH
|
Estramustine
|
Adenocarcinoma (Cell Line: A549)
|
[3] |
|
Estramustine + Aminolevulinic Acid Hydrochloride
|
DCIZBFU
|
Estramustine
|
Large cell lung carcinoma (Cell Line: NCI-H460)
|
[3] |
|
Estramustine + Aminolevulinic Acid Hydrochloride
|
DCXDHZW
|
Estramustine
|
Malignant melanoma (Cell Line: LOX IMVI)
|
[3] |
|
Fludarabine + Aminolevulinic Acid Hydrochloride
|
DCCPZ9Y
|
Fludarabine
|
Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)
|
[2] |
|
Fludarabine + Aminolevulinic Acid Hydrochloride
|
DC2IT87
|
Fludarabine
|
Anaplastic large cell lymphoma (Cell Line: SR)
|
[2] |
|
Fludarabine + Aminolevulinic Acid Hydrochloride
|
DCGYNUP
|
Fludarabine
|
Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)
|
[2] |
|
Fludarabine + Aminolevulinic Acid Hydrochloride
|
DCQE2B8
|
Fludarabine
|
Papillary renal cell carcinoma (Cell Line: ACHN)
|
[2] |
|
Fludarabine + Aminolevulinic Acid Hydrochloride
|
DCWB20R
|
Fludarabine
|
Adenocarcinoma (Cell Line: DU-145)
|
[3] |
|
Fludarabine + Aminolevulinic Acid Hydrochloride
|
DCV29SO
|
Fludarabine
|
Amelanotic melanoma (Cell Line: M14)
|
[3] |
|
Fludarabine + Aminolevulinic Acid Hydrochloride
|
DCEP6DS
|
Fludarabine
|
Lung adenocarcinoma (Cell Line: HOP-62)
|
[3] |
|
FORMESTANE + Aminolevulinic Acid Hydrochloride
|
DC5GHNO
|
FORMESTANE
|
Adenocarcinoma (Cell Line: DU-145)
|
[2] |
|
FORMESTANE + Aminolevulinic Acid Hydrochloride
|
DCREEZQ
|
FORMESTANE
|
Adenocarcinoma (Cell Line: OVCAR3)
|
[2] |
|
FORMESTANE + Aminolevulinic Acid Hydrochloride
|
DCCMIO0
|
FORMESTANE
|
Adenocarcinoma (Cell Line: A549)
|
[2] |
|
FORMESTANE + Aminolevulinic Acid Hydrochloride
|
DCXC3ZT
|
FORMESTANE
|
Adenocarcinoma (Cell Line: HCT116)
|
[2] |
|
FORMESTANE + Aminolevulinic Acid Hydrochloride
|
DCIJ5R8
|
FORMESTANE
|
Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)
|
[2] |
|
FORMESTANE + Aminolevulinic Acid Hydrochloride
|
DCTY4T4
|
FORMESTANE
|
Astrocytoma (Cell Line: U251)
|
[2] |
|
FORMESTANE + Aminolevulinic Acid Hydrochloride
|
DCCAL30
|
FORMESTANE
|
Large cell lung carcinoma (Cell Line: NCI-H460)
|
[2] |
|
FORMESTANE + Aminolevulinic Acid Hydrochloride
|
DCOS3SZ
|
FORMESTANE
|
Malignant melanoma (Cell Line: LOX IMVI)
|
[2] |
|
FORMESTANE + Aminolevulinic Acid Hydrochloride
|
DCQWFKN
|
FORMESTANE
|
Melanoma (Cell Line: MALME-3M)
|
[2] |
|
FORMESTANE + Aminolevulinic Acid Hydrochloride
|
DC2CZ2L
|
FORMESTANE
|
Renal cell carcinoma (Cell Line: SN12C)
|
[2] |
|
Fulvestrant + Aminolevulinic Acid Hydrochloride
|
DCYTBMP
|
Fulvestrant
|
Adenocarcinoma (Cell Line: DU-145)
|
[2] |
|
Fulvestrant + Aminolevulinic Acid Hydrochloride
|
DCR5K5S
|
Fulvestrant
|
Adenocarcinoma (Cell Line: A549)
|
[2] |
|
Fulvestrant + Aminolevulinic Acid Hydrochloride
|
DCL75SL
|
Fulvestrant
|
Melanoma (Cell Line: MALME-3M)
|
[2] |
|
Gefitinib + Aminolevulinic Acid Hydrochloride
|
DCQWQCA
|
Gefitinib
|
Adenocarcinoma (Cell Line: HT29)
|
[2] |
|
Gefitinib + Aminolevulinic Acid Hydrochloride
|
DC2MDAW
|
Gefitinib
|
Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)
|
[2] |
|
Gefitinib + Aminolevulinic Acid Hydrochloride
|
DCKNKCZ
|
Gefitinib
|
Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)
|
[2] |
|
Gefitinib + Aminolevulinic Acid Hydrochloride
|
DCZTPS3
|
Gefitinib
|
Chronic myelogenous leukemia (Cell Line: K-562)
|
[2] |
|
Gefitinib + Aminolevulinic Acid Hydrochloride
|
DC5ZEIT
|
Gefitinib
|
Clear cell renal cell carcinoma (Cell Line: A498)
|
[2] |
|
Gefitinib + Aminolevulinic Acid Hydrochloride
|
DC42723
|
Gefitinib
|
High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)
|
[2] |
|
Gefitinib + Aminolevulinic Acid Hydrochloride
|
DC2O9UP
|
Gefitinib
|
Large cell lung carcinoma (Cell Line: NCI-H460)
|
[2] |
|
Gefitinib + Aminolevulinic Acid Hydrochloride
|
DCIQD73
|
Gefitinib
|
Renal cell carcinoma (Cell Line: SN12C)
|
[2] |
|
Gefitinib + Aminolevulinic Acid Hydrochloride
|
DC98M4B
|
Gefitinib
|
Renal cell carcinoma (Cell Line: UO-31)
|
[2] |
|
Gefitinib + Aminolevulinic Acid Hydrochloride
|
DC1ATEP
|
Gefitinib
|
Invasive ductal carcinoma (Cell Line: T-47D)
|
[4] |
|
Hepzato + Aminolevulinic Acid Hydrochloride
|
DCA9UL7
|
Hepzato
|
Carcinoma (Cell Line: MCF7)
|
[4] |
|
Idarubicin + Aminolevulinic Acid Hydrochloride
|
DCDPUAR
|
Idarubicin
|
Glioma (Cell Line: SF-539)
|
[2] |
|
Imatinib + Aminolevulinic Acid Hydrochloride
|
DCKV33H
|
Imatinib
|
Adenocarcinoma (Cell Line: A549)
|
[2] |
|
Indazole derivative 5 + Aminolevulinic Acid Hydrochloride
|
DC2QDGI
|
Indazole derivative 5
|
Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)
|
[2] |
|
Indazole derivative 5 + Aminolevulinic Acid Hydrochloride
|
DCBMN0J
|
Indazole derivative 5
|
Anaplastic large cell lymphoma (Cell Line: SR)
|
[2] |
|
Indazole derivative 5 + Aminolevulinic Acid Hydrochloride
|
DCVTF4M
|
Indazole derivative 5
|
Amelanotic melanoma (Cell Line: M14)
|
[3] |
|
Indazole derivative 5 + Aminolevulinic Acid Hydrochloride
|
DCM6GU9
|
Indazole derivative 5
|
High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8)
|
[3] |
|
JNK-IN-8 + Aminolevulinic Acid Hydrochloride
|
DCBKGCS
|
JNK-IN-8
|
Anaplastic large cell lymphoma (Cell Line: SR)
|
[2] |
|
Lapatinib + Aminolevulinic Acid Hydrochloride
|
DCRGVZS
|
Lapatinib
|
Adenocarcinoma (Cell Line: DU-145)
|
[3] |
|
Lapatinib + Aminolevulinic Acid Hydrochloride
|
DCXRLMR
|
Lapatinib
|
Adenocarcinoma (Cell Line: OVCAR3)
|
[3] |
|
Lapatinib + Aminolevulinic Acid Hydrochloride
|
DCQ4PUZ
|
Lapatinib
|
Astrocytoma (Cell Line: SNB-19)
|
[3] |
|
Lapatinib + Aminolevulinic Acid Hydrochloride
|
DCGIJQ3
|
Lapatinib
|
Large cell lung carcinoma (Cell Line: NCI-H460)
|
[3] |
|
Lapatinib + Aminolevulinic Acid Hydrochloride
|
DC92GRQ
|
Lapatinib
|
Malignant melanoma (Cell Line: LOX IMVI)
|
[3] |
|
Lenalidomide + Aminolevulinic Acid Hydrochloride
|
DCZF0L0
|
Lenalidomide
|
Amelanotic melanoma (Cell Line: MDA-MB-435)
|
[3] |
|
Lenalidomide + Aminolevulinic Acid Hydrochloride
|
DC3YRWM
|
Lenalidomide
|
Melanoma (Cell Line: SK-MEL-2)
|
[3] |
|
Letrozole + Aminolevulinic Acid Hydrochloride
|
DCGZ49A
|
Letrozole
|
Adenocarcinoma (Cell Line: DU-145)
|
[2] |
|
Letrozole + Aminolevulinic Acid Hydrochloride
|
DCB0Y5X
|
Letrozole
|
Adenocarcinoma (Cell Line: OVCAR3)
|
[2] |
|
Letrozole + Aminolevulinic Acid Hydrochloride
|
DCDSZO9
|
Letrozole
|
Adenocarcinoma (Cell Line: A549)
|
[2] |
|
Letrozole + Aminolevulinic Acid Hydrochloride
|
DCFVQCX
|
Letrozole
|
Astrocytoma (Cell Line: U251)
|
[2] |
|
Letrozole + Aminolevulinic Acid Hydrochloride
|
DCMQOAO
|
Letrozole
|
Glioma (Cell Line: SF-268)
|
[2] |
|
Letrozole + Aminolevulinic Acid Hydrochloride
|
DCZZ385
|
Letrozole
|
Large cell lung carcinoma (Cell Line: NCI-H460)
|
[2] |
|
Letrozole + Aminolevulinic Acid Hydrochloride
|
DCL0X0Z
|
Letrozole
|
Lung adenocarcinoma (Cell Line: MDA-MB-231)
|
[2] |
|
Letrozole + Aminolevulinic Acid Hydrochloride
|
DC4RWV5
|
Letrozole
|
Lung adenocarcinoma (Cell Line: HOP-62)
|
[2] |
|
Letrozole + Aminolevulinic Acid Hydrochloride
|
DCDDPEY
|
Letrozole
|
Malignant melanoma (Cell Line: LOX IMVI)
|
[2] |
|
Letrozole + Aminolevulinic Acid Hydrochloride
|
DCTYF5J
|
Letrozole
|
Melanoma (Cell Line: SK-MEL-2)
|
[2] |
|
Letrozole + Aminolevulinic Acid Hydrochloride
|
DCWI76F
|
Letrozole
|
Papillary renal cell carcinoma (Cell Line: ACHN)
|
[2] |
|
LIAROZOLE + Aminolevulinic Acid Hydrochloride
|
DCJI90F
|
LIAROZOLE
|
Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)
|
[2] |
|
LIAROZOLE + Aminolevulinic Acid Hydrochloride
|
DC1YS76
|
LIAROZOLE
|
Anaplastic large cell lymphoma (Cell Line: SR)
|
[2] |
|
LIAROZOLE + Aminolevulinic Acid Hydrochloride
|
DCFQDMA
|
LIAROZOLE
|
Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)
|
[2] |
|
LIAROZOLE + Aminolevulinic Acid Hydrochloride
|
DCOODEK
|
LIAROZOLE
|
Clear cell renal cell carcinoma (Cell Line: CAKI-1)
|
[2] |
|
LIAROZOLE + Aminolevulinic Acid Hydrochloride
|
DCDXOZI
|
LIAROZOLE
|
Amelanotic melanoma (Cell Line: M14)
|
[3] |
|
LIAROZOLE + Aminolevulinic Acid Hydrochloride
|
DCVDZQ1
|
LIAROZOLE
|
Pleural epithelioid mesothelioma (Cell Line: NCI-H226)
|
[3] |
|
Mepacrine + Aminolevulinic Acid Hydrochloride
|
DC047G2
|
Mepacrine
|
Adenocarcinoma (Cell Line: DU-145)
|
[3] |
|
Mepacrine + Aminolevulinic Acid Hydrochloride
|
DCRZ59J
|
Mepacrine
|
Melanoma (Cell Line: MALME-3M)
|
[3] |
|
Mercaptopurine + Aminolevulinic Acid Hydrochloride
|
DCODK40
|
Mercaptopurine
|
Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)
|
[2] |
|
Mercaptopurine + Aminolevulinic Acid Hydrochloride
|
DCOHXK2
|
Mercaptopurine
|
Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)
|
[2] |
|
Mercaptopurine + Aminolevulinic Acid Hydrochloride
|
DCGMMFG
|
Mercaptopurine
|
Carcinoma (Cell Line: RXF 393)
|
[4] |
|
Mercaptopurine + Aminolevulinic Acid Hydrochloride
|
DCF1M7W
|
Mercaptopurine
|
Large cell lung carcinoma (Cell Line: NCI-H460)
|
[3] |
|
Methotrexate + Aminolevulinic Acid Hydrochloride
|
DC3J00Z
|
Methotrexate
|
Adenocarcinoma (Cell Line: DU-145)
|
[2] |
|
Methotrexate + Aminolevulinic Acid Hydrochloride
|
DCG2ODZ
|
Methotrexate
|
Astrocytoma (Cell Line: U251)
|
[2] |
|
Nilotinib + Aminolevulinic Acid Hydrochloride
|
DCWUWFR
|
Nilotinib
|
Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)
|
[2] |
|
Nilotinib + Aminolevulinic Acid Hydrochloride
|
DCBME2T
|
Nilotinib
|
Anaplastic large cell lymphoma (Cell Line: SR)
|
[2] |
|
Nilotinib + Aminolevulinic Acid Hydrochloride
|
DCPTL1Z
|
Nilotinib
|
Adenocarcinoma (Cell Line: DU-145)
|
[3] |
|
Nilotinib + Aminolevulinic Acid Hydrochloride
|
DCHLBSK
|
Nilotinib
|
Adenocarcinoma (Cell Line: A549)
|
[3] |
|
Nilotinib + Aminolevulinic Acid Hydrochloride
|
DCRLHAS
|
Nilotinib
|
Large cell lung carcinoma (Cell Line: NCI-H460)
|
[3] |
|
PMID28460551-Compound-2 + Aminolevulinic Acid Hydrochloride
|
DCRN6DQ
|
PMID28460551-Compound-2
|
Astrocytoma (Cell Line: U251)
|
[2] |
|
PMID28460551-Compound-2 + Aminolevulinic Acid Hydrochloride
|
DC0Z1Y5
|
PMID28460551-Compound-2
|
Breast adenocarcinoma (Cell Line: MDA-MB-468)
|
[4] |
|
PMID28460551-Compound-2 + Aminolevulinic Acid Hydrochloride
|
DCQKV10
|
PMID28460551-Compound-2
|
Invasive ductal carcinoma (Cell Line: T-47D)
|
[4] |
|
PMID28460551-Compound-2 + Aminolevulinic Acid Hydrochloride
|
DC64I1I
|
PMID28460551-Compound-2
|
Adenocarcinoma (Cell Line: DU-145)
|
[3] |
|
PMID28460551-Compound-2 + Aminolevulinic Acid Hydrochloride
|
DCZGO4H
|
PMID28460551-Compound-2
|
Adenocarcinoma (Cell Line: A549)
|
[3] |
|
PMID28460551-Compound-2 + Aminolevulinic Acid Hydrochloride
|
DC470GH
|
PMID28460551-Compound-2
|
Amelanotic melanoma (Cell Line: M14)
|
[3] |
|
PMID28460551-Compound-2 + Aminolevulinic Acid Hydrochloride
|
DCG9STD
|
PMID28460551-Compound-2
|
Large cell lung carcinoma (Cell Line: NCI-H460)
|
[3] |
|
PMID28460551-Compound-2 + Aminolevulinic Acid Hydrochloride
|
DCRQPEM
|
PMID28460551-Compound-2
|
Malignant melanoma (Cell Line: LOX IMVI)
|
[3] |
|
PMID28460551-Compound-2 + Aminolevulinic Acid Hydrochloride
|
DC45DTY
|
PMID28460551-Compound-2
|
Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M)
|
[3] |
|
Pralatrexate + Aminolevulinic Acid Hydrochloride
|
DCMP0SE
|
Pralatrexate
|
Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)
|
[2] |
|
Pralatrexate + Aminolevulinic Acid Hydrochloride
|
DCBSQXS
|
Pralatrexate
|
Malignant melanoma (Cell Line: LOX IMVI)
|
[3] |
|
Raloxifene + Aminolevulinic Acid Hydrochloride
|
DCE6P9R
|
Raloxifene
|
Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)
|
[2] |
|
Raloxifene + Aminolevulinic Acid Hydrochloride
|
DC3IB8N
|
Raloxifene
|
Adenocarcinoma (Cell Line: A549)
|
[3] |
|
Raloxifene + Aminolevulinic Acid Hydrochloride
|
DC6GS5L
|
Raloxifene
|
Amelanotic melanoma (Cell Line: MDA-MB-435)
|
[3] |
|
Raloxifene + Aminolevulinic Acid Hydrochloride
|
DCVO5JS
|
Raloxifene
|
High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4)
|
[3] |
|
Raloxifene + Aminolevulinic Acid Hydrochloride
|
DCJN0IG
|
Raloxifene
|
Melanoma (Cell Line: SK-MEL-2)
|
[3] |
|
Romidepsin + Aminolevulinic Acid Hydrochloride
|
DCM5Z4F
|
Romidepsin
|
Astrocytoma (Cell Line: U251)
|
[2] |
|
Romidepsin + Aminolevulinic Acid Hydrochloride
|
DCH90BR
|
Romidepsin
|
Glioblastoma (Cell Line: SNB-75)
|
[2] |
|
Romidepsin + Aminolevulinic Acid Hydrochloride
|
DCMQ0TQ
|
Romidepsin
|
Breast adenocarcinoma (Cell Line: MDA-MB-468)
|
[4] |
|
Romidepsin + Aminolevulinic Acid Hydrochloride
|
DCNOZHK
|
Romidepsin
|
Large cell lung carcinoma (Cell Line: NCI-H460)
|
[3] |
|
Romidepsin + Aminolevulinic Acid Hydrochloride
|
DCN6VAJ
|
Romidepsin
|
Lung adenocarcinoma (Cell Line: HOP-62)
|
[3] |
|
Romidepsin + Aminolevulinic Acid Hydrochloride
|
DCMRRV9
|
Romidepsin
|
Lung adenocarcinoma (Cell Line: NCI-H522)
|
[3] |
|
Romidepsin + Aminolevulinic Acid Hydrochloride
|
DCB09N8
|
Romidepsin
|
Malignant melanoma (Cell Line: LOX IMVI)
|
[3] |
|
Ruxolitinib + Aminolevulinic Acid Hydrochloride
|
DCIQSTY
|
Ruxolitinib
|
Lung adenocarcinoma (Cell Line: EKVX)
|
[3] |
|
SCH 727965 + Aminolevulinic Acid Hydrochloride
|
DC7Y3VC
|
SCH 727965
|
Adult acute myeloid leukemia (Cell Line: HL-60(TB))
|
[2] |
|
SCH 727965 + Aminolevulinic Acid Hydrochloride
|
DCCIOMO
|
SCH 727965
|
Astrocytoma (Cell Line: U251)
|
[2] |
|
SCH 727965 + Aminolevulinic Acid Hydrochloride
|
DCCTON2
|
SCH 727965
|
Glioma (Cell Line: SF-268)
|
[2] |
|
SCH 727965 + Aminolevulinic Acid Hydrochloride
|
DC97O66
|
SCH 727965
|
Adenocarcinoma (Cell Line: HCT116)
|
[3] |
|
SCH 727965 + Aminolevulinic Acid Hydrochloride
|
DCUMC3M
|
SCH 727965
|
Large cell lung carcinoma (Cell Line: NCI-H460)
|
[3] |
|
SCH 727965 + Aminolevulinic Acid Hydrochloride
|
DCEW2EM
|
SCH 727965
|
Malignant melanoma (Cell Line: LOX IMVI)
|
[3] |
|
SCH 727965 + Aminolevulinic Acid Hydrochloride
|
DCK2BTG
|
SCH 727965
|
Melanoma (Cell Line: MALME-3M)
|
[3] |
|
Sirolimus + Aminolevulinic Acid Hydrochloride
|
DCG8C0E
|
Sirolimus
|
Clear cell renal cell carcinoma (Cell Line: CAKI-1)
|
[2] |
|
Sirolimus + Aminolevulinic Acid Hydrochloride
|
DCKS8CX
|
Sirolimus
|
Adenocarcinoma (Cell Line: HCT116)
|
[3] |
|
Sirolimus + Aminolevulinic Acid Hydrochloride
|
DCXUGM4
|
Sirolimus
|
Pleural epithelioid mesothelioma (Cell Line: NCI-H226)
|
[3] |
|
Sorafenib + Aminolevulinic Acid Hydrochloride
|
DCQ8SUW
|
Sorafenib
|
Astrocytoma (Cell Line: U251)
|
[2] |
|
Sorafenib + Aminolevulinic Acid Hydrochloride
|
DCL1VUT
|
Sorafenib
|
High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5)
|
[2] |
|
Sorafenib + Aminolevulinic Acid Hydrochloride
|
DC0EA7F
|
Sorafenib
|
Malignant melanoma (Cell Line: LOX IMVI)
|
[2] |
|
Sorafenib + Aminolevulinic Acid Hydrochloride
|
DCJZL7O
|
Sorafenib
|
Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)
|
[2] |
|
Sorafenib + Aminolevulinic Acid Hydrochloride
|
DCLNZWG
|
Sorafenib
|
Renal cell carcinoma (Cell Line: SN12C)
|
[2] |
|
Sorafenib + Aminolevulinic Acid Hydrochloride
|
DCYKREL
|
Sorafenib
|
Invasive ductal carcinoma (Cell Line: T-47D)
|
[4] |
|
SY-1425 + Aminolevulinic Acid Hydrochloride
|
DCTA11M
|
SY-1425
|
Adenocarcinoma (Cell Line: A549)
|
[3] |
|
SY-1425 + Aminolevulinic Acid Hydrochloride
|
DC55UYM
|
SY-1425
|
Adenocarcinoma (Cell Line: HCC-2998)
|
[3] |
|
Taxol + Aminolevulinic Acid Hydrochloride
|
DC9EQ9Q
|
Taxol
|
Large cell lung carcinoma (Cell Line: NCI-H460)
|
[3] |
|
TEM + Aminolevulinic Acid Hydrochloride
|
DCVQ1UG
|
TEM
|
Adult acute myeloid leukemia (Cell Line: HL-60(TB))
|
[2] |
|
TEM + Aminolevulinic Acid Hydrochloride
|
DCUB7LJ
|
TEM
|
Glioma (Cell Line: SF-268)
|
[2] |
|
TEM + Aminolevulinic Acid Hydrochloride
|
DCSVA1P
|
TEM
|
Papillary renal cell carcinoma (Cell Line: ACHN)
|
[2] |
|
TEM + Aminolevulinic Acid Hydrochloride
|
DCVI4ZS
|
TEM
|
Invasive ductal carcinoma (Cell Line: T-47D)
|
[4] |
|
TEM + Aminolevulinic Acid Hydrochloride
|
DCBV0GM
|
TEM
|
Invasive ductal carcinoma (Cell Line: BT-549)
|
[4] |
|
TEM + Aminolevulinic Acid Hydrochloride
|
DCNZPHC
|
TEM
|
Adenocarcinoma (Cell Line: DU-145)
|
[3] |
|
TEM + Aminolevulinic Acid Hydrochloride
|
DCQN8Y1
|
TEM
|
Adenocarcinoma (Cell Line: A549)
|
[3] |
|
TEM + Aminolevulinic Acid Hydrochloride
|
DC31L29
|
TEM
|
Large cell lung carcinoma (Cell Line: NCI-H460)
|
[3] |
|
TEM + Aminolevulinic Acid Hydrochloride
|
DC1CKPZ
|
TEM
|
Lung adenocarcinoma (Cell Line: HOP-62)
|
[3] |
|
TEM + Aminolevulinic Acid Hydrochloride
|
DCDGDPN
|
TEM
|
Melanoma (Cell Line: MALME-3M)
|
[3] |
|
Terameprocol + Aminolevulinic Acid Hydrochloride
|
DCY7GDV
|
Terameprocol
|
Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M)
|
[3] |
|
Thioguanine + Aminolevulinic Acid Hydrochloride
|
DCF4TXI
|
Thioguanine
|
Adult acute myeloid leukemia (Cell Line: HL-60(TB))
|
[2] |
|
Thioguanine + Aminolevulinic Acid Hydrochloride
|
DCHBK8K
|
Thioguanine
|
Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)
|
[2] |
|
Thioguanine + Aminolevulinic Acid Hydrochloride
|
DCU4CR1
|
Thioguanine
|
Anaplastic large cell lymphoma (Cell Line: SR)
|
[2] |
|
Thioguanine + Aminolevulinic Acid Hydrochloride
|
DCH6X5T
|
Thioguanine
|
Astrocytoma (Cell Line: U251)
|
[2] |
|
Thioguanine + Aminolevulinic Acid Hydrochloride
|
DCWF2K0
|
Thioguanine
|
Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)
|
[2] |
|
Thioguanine + Aminolevulinic Acid Hydrochloride
|
DCMSYKV
|
Thioguanine
|
Chronic myelogenous leukemia (Cell Line: K-562)
|
[2] |
|
Thioguanine + Aminolevulinic Acid Hydrochloride
|
DCOQM3I
|
Thioguanine
|
Clear cell renal cell carcinoma (Cell Line: A498)
|
[2] |
|
Thioguanine + Aminolevulinic Acid Hydrochloride
|
DC5S5WD
|
Thioguanine
|
Glioblastoma (Cell Line: SNB-75)
|
[2] |
|
Thioguanine + Aminolevulinic Acid Hydrochloride
|
DCNB60X
|
Thioguanine
|
Papillary renal cell carcinoma (Cell Line: ACHN)
|
[2] |
|
Thioguanine + Aminolevulinic Acid Hydrochloride
|
DCB1AY8
|
Thioguanine
|
Plasma cell myeloma (Cell Line: RPMI-8226)
|
[2] |
|
Thioguanine + Aminolevulinic Acid Hydrochloride
|
DCH6A5K
|
Thioguanine
|
Renal cell carcinoma (Cell Line: SN12C)
|
[2] |
|
Thioguanine + Aminolevulinic Acid Hydrochloride
|
DCR3QLE
|
Thioguanine
|
Colon adenocarcinoma (Cell Line: COLO 205)
|
[4] |
|
Thioguanine + Aminolevulinic Acid Hydrochloride
|
DCSP9NQ
|
Thioguanine
|
Invasive ductal carcinoma (Cell Line: BT-549)
|
[4] |
|
Thioguanine + Aminolevulinic Acid Hydrochloride
|
DCFQOFL
|
Thioguanine
|
Adenocarcinoma (Cell Line: DU-145)
|
[3] |
|
Thioguanine + Aminolevulinic Acid Hydrochloride
|
DCMKSER
|
Thioguanine
|
Adenocarcinoma (Cell Line: NCIH23)
|
[3] |
|
Thioguanine + Aminolevulinic Acid Hydrochloride
|
DCBR7KS
|
Thioguanine
|
Amelanotic melanoma (Cell Line: MDA-MB-435)
|
[3] |
|
Thioguanine + Aminolevulinic Acid Hydrochloride
|
DCCBGPY
|
Thioguanine
|
Cutaneous melanoma (Cell Line: SK-MEL-5)
|
[3] |
|
Thioguanine + Aminolevulinic Acid Hydrochloride
|
DC0PDLZ
|
Thioguanine
|
Large cell lung carcinoma (Cell Line: NCI-H460)
|
[3] |
|
Thioguanine + Aminolevulinic Acid Hydrochloride
|
DCO59D2
|
Thioguanine
|
Lung adenocarcinoma (Cell Line: EKVX)
|
[3] |
|
Thioguanine + Aminolevulinic Acid Hydrochloride
|
DCZX7N9
|
Thioguanine
|
Malignant melanoma (Cell Line: LOX IMVI)
|
[3] |
|
Thioguanine + Aminolevulinic Acid Hydrochloride
|
DC3X18O
|
Thioguanine
|
Melanoma (Cell Line: SK-MEL-2)
|
[3] |
|
Thioguanine + Aminolevulinic Acid Hydrochloride
|
DCXQ3EN
|
Thioguanine
|
Non-small cell lung carcinoma (Cell Line: HOP-92)
|
[3] |
|
Trifluridine + Aminolevulinic Acid Hydrochloride
|
DCBWM3I
|
Trifluridine
|
Anaplastic large cell lymphoma (Cell Line: SR)
|
[2] |
|
Trifluridine + Aminolevulinic Acid Hydrochloride
|
DCPUWBB
|
Trifluridine
|
Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)
|
[2] |
|
Trifluridine + Aminolevulinic Acid Hydrochloride
|
DCIKBT9
|
Trifluridine
|
Papillary renal cell carcinoma (Cell Line: ACHN)
|
[2] |
|
Trifluridine + Aminolevulinic Acid Hydrochloride
|
DCCJVVR
|
Trifluridine
|
Plasma cell myeloma (Cell Line: RPMI-8226)
|
[2] |
|
Trifluridine + Aminolevulinic Acid Hydrochloride
|
DCR9XCI
|
Trifluridine
|
Lung adenocarcinoma (Cell Line: EKVX)
|
[3] |
|
Uracil mustard + Aminolevulinic Acid Hydrochloride
|
DC6U40G
|
Uracil mustard
|
Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)
|
[2] |
|
Uracil mustard + Aminolevulinic Acid Hydrochloride
|
DCCJRH2
|
Uracil mustard
|
Anaplastic large cell lymphoma (Cell Line: SR)
|
[2] |
|
Uracil mustard + Aminolevulinic Acid Hydrochloride
|
DCAUJSW
|
Uracil mustard
|
Invasive ductal carcinoma (Cell Line: BT-549)
|
[4] |
|
Uracil mustard + Aminolevulinic Acid Hydrochloride
|
DCSYT2Y
|
Uracil mustard
|
Large cell lung carcinoma (Cell Line: NCI-H460)
|
[3] |
|
Valrubicin + Aminolevulinic Acid Hydrochloride
|
DCEA479
|
Valrubicin
|
Clear cell renal cell carcinoma (Cell Line: CAKI-1)
|
[2] |
|
Valrubicin + Aminolevulinic Acid Hydrochloride
|
DCMFV1O
|
Valrubicin
|
Malignant melanoma (Cell Line: LOX IMVI)
|
[3] |
|
Vandetanib + Aminolevulinic Acid Hydrochloride
|
DCR87ST
|
Vandetanib
|
High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8)
|
[3] |
|
Vemurafenib + Aminolevulinic Acid Hydrochloride
|
DCEA14E
|
Vemurafenib
|
Malignant melanoma (Cell Line: LOX IMVI)
|
[3] |
|
Vemurafenib + Aminolevulinic Acid Hydrochloride
|
DCXVL55
|
Vemurafenib
|
Malignant melanoma (Cell Line: UACC62)
|
[3] |
|
Vemurafenib + Aminolevulinic Acid Hydrochloride
|
DC8P9EB
|
Vemurafenib
|
Melanoma (Cell Line: SK-MEL-2)
|
[3] |
|
Vincristine + Aminolevulinic Acid Hydrochloride
|
DCPN8RS
|
Vincristine
|
Adenocarcinoma (Cell Line: HCT116)
|
[2] |
|
Vincristine + Aminolevulinic Acid Hydrochloride
|
DC0RZWD
|
Vincristine
|
Adenocarcinoma (Cell Line: HCC-2998)
|
[2] |
|
Vincristine + Aminolevulinic Acid Hydrochloride
|
DCN2IO6
|
Vincristine
|
Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)
|
[2] |
|
Vincristine + Aminolevulinic Acid Hydrochloride
|
DCY0DOR
|
Vincristine
|
Astrocytoma (Cell Line: U251)
|
[2] |
|
Vincristine + Aminolevulinic Acid Hydrochloride
|
DC5IFWU
|
Vincristine
|
Astrocytoma (Cell Line: SNB-19)
|
[2] |
|
Vincristine + Aminolevulinic Acid Hydrochloride
|
DC25TPK
|
Vincristine
|
Chronic myelogenous leukemia (Cell Line: K-562)
|
[2] |
|
Vincristine + Aminolevulinic Acid Hydrochloride
|
DCSWF49
|
Vincristine
|
Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M)
|
[2] |
|
Vincristine + Aminolevulinic Acid Hydrochloride
|
DCNTO37
|
Vincristine
|
Papillary renal cell carcinoma (Cell Line: ACHN)
|
[2] |
|
Vinflunine + Aminolevulinic Acid Hydrochloride
|
DC6K1IF
|
Vinflunine
|
Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)
|
[2] |
|
Vinflunine + Aminolevulinic Acid Hydrochloride
|
DCGGPX4
|
Vinflunine
|
Astrocytoma (Cell Line: U251)
|
[2] |
|
Vinflunine + Aminolevulinic Acid Hydrochloride
|
DCXI460
|
Vinflunine
|
Breast adenocarcinoma (Cell Line: MDA-MB-468)
|
[4] |
|
Vinflunine + Aminolevulinic Acid Hydrochloride
|
DCM0FTK
|
Vinflunine
|
Amelanotic melanoma (Cell Line: MDA-MB-435)
|
[3] |
|
Vinflunine + Aminolevulinic Acid Hydrochloride
|
DCT3M5R
|
Vinflunine
|
High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)
|
[3] |
|
Vismodegib + Aminolevulinic Acid Hydrochloride
|
DCMASTF
|
Vismodegib
|
Amelanotic melanoma (Cell Line: MDA-MB-435)
|
[3] |
|
Vismodegib + Aminolevulinic Acid Hydrochloride
|
DC6CE0F
|
Vismodegib
|
Clear cell renal cell carcinoma (Cell Line: TK-10)
|
[3] |
| ------------------------------------------------------------------------------------ |
|
|
|
|
